Moderna Capitalizes On Its Headstart In COVID-19 Vaccines

Leaked List Shows Premium Price Secured With EU

 
• By Andrew McConaghie
Moderna looks set to earn over $9bn from its COVID-19 vaccine next year.

More from COVID-19

More from Scrip